Determinants of Multidrug-Resistant Mycobacterium tuberculosis Infection: A Multicenter Study from Southern Ethiopia

References

• World Health Organization. Global tuberculosis report 2020. Geneva; 2020. Available from: https://www.who.int/publications-detail.redirect/9789240013131. Accessed June 29, 2022.
   Google Scholar
• The Federal Democratic Republic Of Ethiopia, Ministry of Health (MOH). National Guidelines for TB, DR-TB, and Leprosy in Ethiopia sixth edition 2017. Available from: https://www.afro.who.int/publications/national-guidelines-tb-drug-resistant-tb-and-leprosy-ethiopia-sixth-edition. Accessed June 29, 2022.
   Google Scholar
• CDC. Multidrug-resistantTuberculosis. National Center for HIV/AIDS, Viral Hepatitis, STD, TB Prev; 2012. Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi328KBzuXzAhVMxIUKHdq2CvQQFnoECAMQAQ&url=https%3A%2F%2Fwww.cdc.gov%2Fnchhstp%2Fpublications%2Fdocs%2Fnchhstp-annualreport-2012-508.pdf&usg=AOvVaw08miU8aCDrWufGLBWQkapj. Accessed June 29, 2022.
   Google Scholar
• Ismail N, Omar SV, Ismail F, et al. Drug-resistant tuberculosis in Africa: current status, gaps, and opportunities. Afr J Lab Med. 2018;7(2):1. doi:10.4102/ajlm.v7i2.781
   Web of Science ®Google Scholar
• Girum T, Muktar E, Lentiro K, Wondiye H, Shewangizaw M. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines. 2018;4:1–12. doi:10.1186/s40794-018-0061-9
   Google Scholar
• World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis; 2014. Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwjqw9fkzuXzAhXEzoUKHctVAXIQFnoECAYQAQ&url=https%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2Fhandle%2F10665%2F130918%2F9789241548809_eng.pdf&usg=AOvVaw1JfS7pFYotDNwhFtEqmTrF. Accessed June 29, 2022.
   Google Scholar
• Belay A, Dagnaw WW, Kumsa A, et al. Guidelines On Programmatic Management Of Drug Resistant. 2nd ed ResearchGate; 2014.
   Google Scholar
• Federal Ministry of Health of Ethiopia. National guidelines for management of tb, dr-tb and leprosy in Ethiopia. Addis Ababa; 2018; Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwivheyPzXzAhVOCxoKHVsZAWIQFnoECAIQAQ&url=https%3A%2F%2Fwww.impaact4t.org%2Fwpcontent%2Fuploads%2F2019%2F08%2FEthiopiaNational-guideline-for-TB-Leprosy-and-DR_TB-6th-ed-Aug.2018.pdf&usg=AOvVaw2AiUI9VZiIjlTn1HxJ_AtY. Accessed June 29, 2022.
   Google Scholar
• Biru D, Endrias Markos W. Determinants of drug-resistant tuberculosis in Southern Ethiopia: a Case-Control Study. Infect Drug Resist. 2020;Volume 13:1823–1829. doi:10.2147/IDR.S256536
   Web of Science ®Google Scholar
• Fikre A, Tewelde T, Shaweno T. Determinants of multi-drug resistant tuberculosis among tuberculosis patients in Southern Ethiopia: a case-control study. J Med Bacteriol. 2019;8(1):1–12.
   Google Scholar
• Christof C, Nußbaumer-Streit B, Gartlehner G. WHO-Leitlinie: prävention und Kontrolle von Tuberkulose-Infektionen [WHO Guidelines on Tuberculosis Infection Prevention and Control]. Gesundheitswesen. 2020. 82(11):885–889. PMID: 32977345. doi:10.1055/a-1241-4321
   Web of Science ®Google Scholar
• Stosic M, Vukovic D, Babic D, et al. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study. BMC Public Health. 2018;18(1):1–8. doi:10.1186/s12889-018-6021-5
   Web of Science ®Google Scholar
• Zhang C, Wang Y, Shi G, et al. Determinants of multidrug-resistant tuberculosis in Henan province in China: a case-control study. BMC Public Health. 2015;16(1):1–8. doi:10.1186/s12889-016-2711-z
   Web of Science ®Google Scholar
• Assefa D, Seyoum B, Oljira L. Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia. Infect Drug Resist. 2017;10:209. doi:10.2147/IDR.S134369
   PubMed Web of Science ®Google Scholar
• Workicho A, Kassahun W, Alemseged F. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study. Infect Drug Resist. 2017;10:91. doi:10.2147/IDR.S126274
   PubMed Web of Science ®Google Scholar
• Hirpa S, Medhin G, Girma B, et al. Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case-control study. BMC Public Health. 2013;13(1):1–9. doi:10.1186/1471-2458-13-782
   Web of Science ®Google Scholar
• Tenzin C, Chansatitporn N, Dendup T, et al. Factors associated with multidrug-resistant tuberculosis (MDR-TB) in Bhutan: a nationwide case-control study. PLoS One. 2020;15(7):e0236250. doi:10.1371/journal.pone.0236250
   Web of Science ®Google Scholar
• Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health. 2018;18(1):1–6. doi:10.1186/s12889-018-5371-3
   Web of Science ®Google Scholar
• Elduma AH, Mansournia MA, Foroushani AR, et al. Assessment of the Risk Factors Associated with Multidrug-Resistant Tuberculosis in Sudan: A Case-Control Study. Epidemiology and health; 2019:41.
   Google Scholar
• US WASHINGTON. National action plan for combating multidrug-resistant tuberculosis; 2015. Availablefrom:https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/national_action_plan_for_tuberculosis_20151204_final.pdf. Accessed June 29, 2022.
   Google Scholar
• TB FACTS. ORG. Nutrition & TB - Malnutrition, under nutrition; 2021. Available from: https://tbfacts.org/nutrition-tb/. Accessed June 29, 2022.
   Google Scholar
• Gobena D, Ameya G, Haile K, Abreha G, Worku Y, Debela T. Predictor of multidrug-resistant tuberculosis in the southwestern part of Ethiopia: a case-control study. Ann Clin Microbiol Antimicrob. 2018;17(1):1–7. doi:10.1186/s12941-018-0283-8
   Web of Science ®Google Scholar
• Demile B, Zenebu A, Shewaye H, Xia S, Guadie A. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. BMC Infect Dis. 2018;18(1):1. doi:10.1186/s12879-018-3167-9
   Web of Science ®Google Scholar
• FMOH. Guidelines for management of tb, dr-tb and leprosy in Ethiopia; 2022. Available from: https://www.afro.who.int/sites/default/files/2019-04/Ethiopia-National%20guidelines%20for%20TB%2C%20DR.TB%20and%20Leprosy%20in%20Ethiopia%20-%20Sixth%20Edition.pdf. Accessed June 29, 2022.
   Google Scholar
• Mengesha MM, Gebremichael MA, Watumo D, Hallström IK, Jerene D. Poor adult tuberculosis treatment outcome and associated factors in Gibe Woreda, Southern Ethiopia: an institution-based cross-sectional study. PLOS Global Public Health. 2022;2(3):e0000161. doi:10.1371/journal.pgph.0000161
   Google Scholar
• FMOH. Guidelines for Clinical and Programmatic Management of TB, TB/ HIV, DR-TB and Leprosy. 7th ed. Addis Ababa, Ethiopia; 2021.
   Google Scholar
• Weir CB, Jan A. BMI classification percentile and cut off points. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://pubmed.ncbi.nlm.nih.gov/31082114/. Accessed June 29, 2022.
   Google Scholar